BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
96 hedge funds and large institutions have $293M invested in BioDelivery Sciences International, Inc. in 2014 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 38 increasing their positions, 17 reducing their positions, and 8 closing their positions.
263% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 8
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
124% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 17
115% more capital invested
Capital invested by funds: $137M → $293M (+$156M)
28% more funds holding
Funds holding: 75 → 96 (+21)
63% less call options, than puts
Call options by funds: $2.21M | Put options by funds: $5.99M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$40.4M |
| 2 |
DM
Deerfield Management
New York
|
+$18M |
| 3 |
BC
Broadfin Capital
New York
|
+$10.1M |
| 4 |
FCMI
Foresite Capital Management I
Larkspur,
California
|
+$5.65M |
| 5 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$4.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$10M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$3.43M |
| 3 |
Millennium Management
New York
|
-$1.63M |
| 4 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$1.47M |
| 5 |
SC
Sophrosyne Capital
New York
|
-$1.43M |
BDSI Hedge Fund Activity: Q1 2014 in Review
96 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q1 2014, worth a combined $293M — up 115% from $137M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new BDSI positions and 8 closed out — a net gain of 21 holders — while 38 added to existing stakes and 17 trimmed.
The largest buyer was Federated Hermes, adding an estimated $40.4M. The largest seller was Visium Asset Management, exiting entirely with an estimated $10M sold.
- 96 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q1 2014, up from 75 in Q4 2013.
- Funds reported $293M of BioDelivery Sciences International, Inc. stock for Q1 2014, up 115% quarter-over-quarter.
- 29 funds opened new BioDelivery Sciences International, Inc. positions in Q1 2014 and 8 closed out, a net change of +21 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q1 2014 was Federated Hermes, an estimated $40.4M added.
- The largest BioDelivery Sciences International, Inc. seller in Q1 2014 was Visium Asset Management, an estimated $10M sold.
Based on aggregated 13F filings for Q1 2014.